EpiBiologics | $107,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Recess
start up
United States
- New York, NY
- 30/10/2025
- Series B
- $30,000,000
We created Recess to bring calm and balance to an overstressed generation. From mood enhancing sparkling waters and powders, to RTD mocktails and digital experiences – we make products that help people feel calm cool collected despite the stressful world around them. (In business lingo, you might call us a Relaxation platform.) Recess is antidote to modern times.
- Industry Food and Beverage Services
- Website https://takearecess.com/
- LinkedIn https://www.linkedin.com/company/drinkrecess/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)